Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
Launched by UNIVERSITY OF OKLAHOMA · Jun 6, 2019
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how using a special robotic device, called an exoskeleton, can help patients who have had a stroke improve their ability to walk and regain strength. The study aims to see if this type of training can lead to better recovery outcomes for patients who are undergoing rehabilitation in a hospital setting. Researchers are currently looking for participants who are between the ages of 65 and 87 and have had a stroke that is confirmed by medical imaging.
To be eligible for the study, participants need to be medically stable and able to stand on their own. They should also be able to give written consent to join the study and have a certain level of mental clarity, as measured by a simple test. However, individuals who cannot communicate effectively, are confused, or have other serious medical issues will not be included. Those who participate can expect to receive specialized training with the exoskeleton while working on their rehabilitation goals in a supportive environment. This trial aims to find out if this innovative approach can make a significant difference in recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging.
- • 2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies.
- • 3. Depressed patients will be included in the study
- • 4. Patients able to stand alone
- • 5. Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination \[MMSE\] greater than or equal to 21).
- Exclusion Criteria:
- • 1. Aphasic patients unable to communicate
- • 2. Confused patients
- • 3. Patients medically unstable
- • 4. Patients unable to stand alone
- • 5. Refusal to provide written informed consent
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Patients applied
Trial Officials
Meheroz H Rabadi, MD, MRCPI
Principal Investigator
Affiliate; Oklahoma VA Health Care System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials